JAK inhibitor PF-03394197, Purity ≥98%

Synonym: OCLACITINIB; 1208319-26-9; PF-03394197; PF-03394197(Oclacitinib); JAKI; Oclacitinib [USAN]; N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide; JAK inhibitor

MDL: MFCD25976611
CAS Number: 1208319-26-9
Compound CID: 44631938

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

PF-03394197 is an available JAK small molecule inhibitor with potential antineoplastic activity.

Molecular Weight

337.44

Molecular Formula

C₁₅H₂₃N₅O₂S

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

PF-03394197 is utilized to study JAK kinase inhibition with a focus on JAK1.

Storage

Store at -20ºC.